Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR3 | P51677 | 1/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.59 |
| ▸ | HTR2A | P28223 | 3/20 | 0.58 |
| ▸ | HTR4 | Q13639 | 2/20 | 0.57 |
| ▸ | ACHE | P22303 | 2/20 | 0.55 |
| ▸ | LTA4H | P09960 | 2/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.54 |
| ▸ | FAAH | O00519 | 1/20 | 0.54 |
| ▸ | BCHE | P06276 | 1/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3594120 | 0.86 | MAPT (0.55) | SIGMAR1HTR2AHTR4HDAC1HDAC8 | |
| SCHEMBL3938952 | 0.86 | HRH3 (0.56) | SIGMAR1ACHELTA4HFAAHBCHE | |
| SCHEMBL3598405 | 0.84 | L3MBTL1 (0.50) | CCR3SIGMAR1HTR2AHTR4LTA4H | |
| SCHEMBL22594946 | 0.84 | HTR2A (0.59) | CCR3SIGMAR1HTR2AHTR4ACHE | |
| SCHEMBL23122571 | 0.83 | CCR3 (0.58) | CCR3SIGMAR1HTR2AHTR4ACHE | |
| SCHEMBL3594346 | 0.82 | LTA4H (0.55) | ACHELTA4HFAAHBCHE | |
| SCHEMBL24833934 | 0.82 | SIGMAR1 (0.57) | CCR3SIGMAR1HTR2AHTR4LTA4H | |
| Hydrochloric Acid SCHEMBL23122745 | 0.82 | CCR3 (0.57) | CCR3SIGMAR1HTR2AHTR4ACHE | |
| Hydrochloric Acid SCHEMBL23122337 | 0.82 | CCR3 (0.57) | CCR3SIGMAR1HTR2AHTR4ACHE | |
| SCHEMBL3938247 | 0.81 | HTR1A (0.53) | SIGMAR1HTR2AHTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002356-A1 | COMPOUNDS AND USES THEREOF | PANO THERAPEUTICS, INC. (US) | 2023-01-05 | — | — | US | disclosed |
| WO-2021055637-A1 | COMPOUNDS AND USES THEREOF | PANO THERAPEUTICS, INC. (US) | 2021-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002356-A1 | COMPOUNDS AND USES THEREOF | HIF1AN, HIF1A, EGLN2 | CCR3 3574/4885SIGMAR1 2406/4885HTR2A 4181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.